Reports for HIKMA CANADA LIMITED
Company Name
HIKMA CANADA LIMITED
Totals |
||
Shortage reports |
82 |
|
| Actual shortage: | 12 (15%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (1%) | |
| Resolved: | 69 (84%) | |
Discontinuation Reports |
4 |
|
| To be discontinued: | 3 (75%) | |
| Discontinued: | 1 (25%) | |
| Reversed: | 0 (0%) | |
Late reports |
16 (19%) |
|
Overdue reports |
9 (60%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-04-17 | 2023-09-05 | 189738 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-05-26 | 2024-02-01 | 193247 |
| SUCCINYLCHOLINE CHLORIDE INJECTION USP | 20MG | SOLUTION | Resolved | 2023-10-02 | 2024-01-30 | 205822 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2022-04-14 | 2022-06-07 | 158877 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2017-11-30 | 2017-12-14 | 31386 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2020-12-25 | 130358 |
| PHENYTOIN SODIUM INJECTION USP | 50MG | SOLUTION | Resolved | 2020-12-17 | 2021-01-20 | 130361 |
| ATROPINE INJECTION BP | 0.4MG | SOLUTION | Resolved | 2018-08-10 | 2018-09-04 | 57885 |
| ATROPINE INJECTION BP | 0.4MG | SOLUTION | Resolved | 2023-11-17 | 2024-04-16 | 210686 |
| ATROPINE INJECTION BP | 0.6MG | SOLUTION | Resolved | 2023-11-17 | 2024-04-17 | 210691 |
| DIMENHYDRINATE INJECTION USP | 50MG | SOLUTION | Resolved | 2018-02-15 | 2018-05-16 | 39961 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2017-12-22 | 2018-07-09 | 34254 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2018-09-27 | 2018-11-30 | 62439 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-01-22 | 2019-01-30 | 73273 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-02-19 | 2019-06-19 | 76329 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2019-12-20 | 2020-02-21 | 101864 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-03-30 | 2022-04-28 | 157571 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2022-06-20 | 2022-08-16 | 163112 |
| EPINEPHRINE INJECTION USP | 1MG | SOLUTION | Resolved | 2023-08-03 | 2024-03-28 | 200978 |
| LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP | 20MG 0.01MG | SOLUTION | Resolved | 2017-12-22 | 2018-02-15 | 34258 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-04-19 | 2024-04-22 | 225805 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 2G 0.25G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165188 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165193 |
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | To be discontinued | 2022-07-21 | 2022-07-21 | 165196 |
Showing 1 to 4 of 4